Product Images Inbrija
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 30 images provide visual information about the product associated with Inbrija NDC 10144-342 by Acorda Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - inbrija 01
Figure 1 - inbrija 02
The text describes a table or graph displaying data on a variable labeled "quare Mean + SE". The other information present includes a "Least-S" value, "N" value of 15, and two groups labeled "Placebo" and "W INBRWA 84 mg" with respective "N" values of 112 and 114. The graph also includes a time axis labeled in minutes from 20 to 60.*
Figure A - inbrija 03
Figure B - inbrija 04
Figure C - inbrija 05
Figure D - inbrija 06
Figure E - inbrija 07
The text indicates that there is a tear off package which contains 2 capsules. However, without additional context regarding what the capsules are for or what is depicted in the accompanying Fig.E, the description may not be very useful.*
Figure F - inbrija 08
Figure G - inbrija 09
Figure H - inbrija 10
Figure I - inbrija 11
Figure J - inbrija 12
Figure K - inbrija 13
Not available.*
Figure L - inbrija 14
Figure M - inbrija 15
Figure N - inbrija 16
Figure O - inbrija 17
Figure P - inbrija 18
Figure Q - inbrija 19
Figure R - inbrija 20
Figure S - inbrija 21
Figure T - inbrija 22
Figure U - inbrija 23
inbrija 23a
Figure V - inbrija 24
inbrija 24a
Figure W - inbrija 25
Principal Display Panel - 42 mg Capsule Blister Pack Carton - inbrija 26
Inbrija is a medication for oral inhalation only, contained in capsules that each contain 42mg levodopa. The capsules should always be stored in the blister and only removed immediately before use. The active ingredients also include DPPC and sodium chloride. The enclosed Patient Information and Instructions for Use should be read before using Inbrija. The NDC number is 10144-342-60.*
inbrija 27
Inbrija is a levodopa inhalation powder that comes in capsules of 42 mg for oral inhalation only. The capsules should not be swallowed and are intended for a usual dosage which can be found in the prescribing information. Each Inbrija capsule contains 42 mg levodopa and other inactive ingredients such as DPPC, sodium chloride. It should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). Additionally, it should always be stored in the blister and only removed immediately before use. The enclosed patient information and instructions for use should be reviewed before taking. The manufacturing company is Acorda Therapeutics, Inc.*
inbrija 28
Inbrija is a medication used for oral inhalation only and contains 42 mg levodopa per capsule. The capsules should not be swallowed and should be stored between 20°C to 25°C (68°F to 77°F). The patient information enclosed must be read before use. The medication is manufactured by Acorda Therapeutics and comes in a blister pack with a lot number and expiration date.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.